Fat graft may keep Dupuytren's disease from returning after surgery
NCT ID NCT05067764
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
Dupuytren's disease causes fingers to bend inward, making hand use difficult. This study compares standard surgery (aponeurectomy) alone versus surgery plus a fat graft taken from the patient's arm. Researchers will track 172 adults for 2 years to see if the fat graft reduces the chance of the disease coming back.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- adipose tissue (fat) graft
- What this could lead to
- If it works, this could offer a simple way to reduce the chance of Dupuytren's coming back after surgery, helping people keep hand function longer.
- What could go wrong
- This is a relatively small, early-stage trial. The fat graft may not lower recurrence rates, and there are risks like infection or graft failure. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUPUYTREN'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Aquitain de la Main
RECRUITINGPessac, 33600, France
-
Santé Atlantique ELSAN
RECRUITINGSaint-Herblain, 44800, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Vitamin e gel could stop Dupuytren's before fingers curl
- New device may straighten bent fingers without surgery
- Tiny hand nerves may hold key to Dupuytren's return
- Missing hand muscle may shield against dupuytren disease
- New study aims to predict surgery needs for common hand condition
- Can radiation after surgery stop Dupuytren's from coming back?